PHOTOLEG

Development of Photochromic Ligands for Selectively Expressed Glutamate Receptors

 Coordinatore LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

 Organization address address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539

contact info
Titolo: Prof.
Nome: Dirk
Cognome: Trauner
Email: send email
Telefono: +49 89218077800

 Nazionalità Coordinatore Germany [DE]
 Totale costo 161˙968 €
 EC contributo 161˙968 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2013-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-05-01   -   2016-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

 Organization address address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539

contact info
Titolo: Prof.
Nome: Dirk
Cognome: Trauner
Email: send email
Telefono: +49 89218077800

DE (MUENCHEN) coordinator 161˙968.80

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

significant    significantly    networks    debilitating    cell    diseases    selectively    disease    brain    life    glurs    neural    onset    disorders    turned    world    dark    light    linked    us    treat    pcls    degenerative    neurological   

 Obiettivo del progetto (Objective)

'As life expectancies across the world continue to increase, the number of people suffering from a degenerative neurological disorder such as Parkinson’s disease and Alzheimer’s disease also rapidly increases. This is a significant problem (particularly in the developed world), with sufferers regularly experiencing a poor quality of life which often leaves them requiring costly round-the-clock care. Current pharmaceuticals have had some success in treating specific neurological disorders, but their effects are significantly limited as they generally only slow the progression of the disease. Consequently, there is a significant need for new and innovative methods to treat these debilitating neurological conditions. Researchers have established that some neurological disorders are caused by the break-down of neural networks in the brain. This has since been linked to the malfunction of glutamate receptors (GluRs) found in the cell membranes of neurons. In this Fellowship, we propose that new families of photochromic ligands (PCLs) that selectively and reversibly control GluRs using light, could be used to 'reactivate' unresponsive neural networks in the brain, allowing for the development of new and pioneering treatments for neurological disorders. To accomplish this we will develop new PCLs that are 'turned-on' by low energy 'red-shifted' light and then are rapidly 'turned-off' in the dark. This will significantly advance the current state of the art PCLs which are 'turned-on' in the dark, making them unsuitable for therapeutic applications. The new PCLs will target GluRs that are selectively expressed in particular cell types in the brain that are linked with the onset of degenerative neurological diseases. This will allow us to extensively study the role these GluRs play in the onset of neurological disorders, thus enabling us to develop new methods to treat these debilitating diseases.'

Altri progetti dello stesso programma (FP7-PEOPLE)

ARABIGANS (2010)

Uncovering conserved proliferation pathways between plants and animals

Read More  

HELTSTACK (2014)

HIGH EFFICIENCY LOW TEMPERATURE SOFC STACK

Read More  

MONTENIGHT2010 (2010)

Researchers' Night in Montenegro 2010

Read More